Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes CareBusiness Wire • 02/05/26
Insulet Corporation (PODD) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026Business Wire • 01/09/26
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected HealthBusiness Wire • 01/06/26
Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable FutureBusiness Wire • 12/15/25
PODD Stock Benefits From FDA Approval of Omnipod 5's EnhancementsZacks Investment Research • 12/08/25
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod ExperienceBusiness Wire • 12/04/25
Looking for a Growth Stock? 3 Reasons Why Insulet (PODD) is a Solid ChoiceZacks Investment Research • 11/24/25
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor DayBusiness Wire • 11/20/25